Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
CCG-1423
Cat. No.:
OB0225LY-0057
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
CCG-1423 is a selective RhoA pathway inhibitor that targets signaling pathways that mediate apoptosis and growth.
Synonym:
CCG1423; 285986-88-1; N-(2-(4-Chloroanilino)-1-methyl-2-oxoethoxy)-3,5-bis(trifluoromethyl)benzamide; N-[1-(4-Chloroanilino)-1-oxopropan-2-yl]oxy-3,5-bis(trifluoromethyl)benzamide; Benzamide, N-[2-[(4-chlorophenyl)amino]-1-methyl-2-oxoethoxy]-3,5-bis(trifluoromethyl)-; N-((1-((4-Chlorophenyl)amino)-1-oxopropan-2-yl)oxy)-3,5-bis(trifluoromethyl)benzamide; N-[2-[4(4-chlorophenyl)amino]-1-methyl-2-oxoethoxy]-3,5-bis(trifluoromethyl)-benzamide
CAS No.:
285986-88-1
Compound CID:
2726015
Formula:
C18H13ClF6N2O3
Formula Weight:
454.75
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
CCG-1423 can be used to study the mechanisms related to cell proliferation and apoptosis and aid in drug development.
Library Information
Targets:
GTPase superfamily; Kinases
Receptors:
LRRK2; Ras; RhoA
Pathways:
Autophagy; MAPK; GPCR/G protein; Cell cycle/Checkpoint
Plate Number:
AOCL-1
Plate Location:
f9
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
83 mg/mL; 182.5 mM
Water Max Solubility:
<1 mg/mL (insoluble or slightly soluble)
Ethanol Max Solubility:
4 mg/mL; 8.79 mM
